AskAt received an Issue Notification from the U.S. Patent and Trademark Office (USPTO) dated April 23, 2024 for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730 (Patent Number: 11,964,963). The Notification was issued in connection with Application Number 18/035,195 (Filing Date: November 11, 2021). In addition to the U.S., salt and crystal forms patents have also been granted in Australia, Brazil, Canada, China, Japan, Korea, and Mexico.